NYSE · Healthcare · Medical Instruments & Supplies · USA
West Pharmaceutical Services Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Instruments & Supplies industry.
West Pharmaceutical Services produces containment solutions and delivery mechanisms for injectable medications and medical products, encompassing stoppers, syringes, cartridges, and self-injection devices. Operating through Proprietary Products and Contract-Manufactured Products divisions, the company serves pharmaceutical, biologic, diagnostic, and medical device manufacturers with facilities across North America, Europe, and Asia.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the West Pharmaceutical Services Inc stock.
Overvalued: intrinsic value $113.95 per share, market price $383.91, margin of safety -236.9% (as of 2026-10-19).
Discounting its cash flows at 10.5% (average of 3 methods) values the shares at $113.95; the price of $383.91 is 237% above that value, and 71% of that value comes from beyond year five.
Leak Score: 51/100 on 12 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
17 more in this industry show a wider margin of safety.
WST is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 10.5% (average of 3 methods) values the shares at $113.95; the price of $383.91 is 237% above that value, and 71% of that value comes from beyond year five.
$113.95 per share (as of the 2026-10-19 close), against a market price of $383.91. That is a margin of safety of -236.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
51 out of 100, which we rate "Weak Signal", on 12 of 12 value investing signals.